Inhibition of Band 3 tyrosine phosphorylation: a new mechanism for treatment of sickle cell disease. [electronic resource]
Producer: 20210304Description: 599-609 p. digitalISSN:- 1365-2141
- Anemia, Sickle Cell -- blood
- Anion Exchange Protein 1, Erythrocyte -- metabolism
- Cell Adhesion -- drug effects
- Cell-Derived Microparticles -- chemistry
- Drug Evaluation, Preclinical
- Endothelium, Vascular -- metabolism
- Erythrocyte Deformability -- drug effects
- Erythrocyte Membrane -- drug effects
- Erythrocytes, Abnormal -- drug effects
- Hemoglobin, Sickle -- analysis
- Humans
- Imatinib Mesylate -- pharmacology
- Oxidative Stress
- Oxygen -- blood
- Phosphorylation -- drug effects
- Phosphotyrosine -- metabolism
- Plasma
- Protein Kinase Inhibitors -- pharmacology
- Protein Processing, Post-Translational -- drug effects
- Sickle Cell Trait -- blood
- beta-Thalassemia -- blood
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.